NCT03845387View on ClinicalTrials.gov

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 26, 2019

Primary Completion Date

February 21, 2020

Study Completion Date

February 21, 2020

Conditions
Parkinson Disease
Interventions
DRUG

KDT-3594

oral administration, dose titration

DRUG

Pramipexole

ER formulation, oral administration, dose titration

Trial Locations (1)

Unknown

Research Site, Multiple Locations

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY